Phylogeny of the clinically relevant species of the emerging fungus Trichoderma and their antifungal susceptibilities.
J Clin Microbiol, 2014/6;52(6):2112-25.
Sandoval-Denis M[1], Sutton DA[2], Cano-Lira JF[1], Gené J[3], Fothergill AW[2], Wiederhold NP[2], Guarro J[1]
Affiliations
PMID: 24719448DOI: 10.1128/JCM.00429-14
Impact factor: 11.677
Abstract
A set of 73 isolates of the emerging fungus Trichoderma isolated from human and animal clinical specimens were characterized morphologically and molecularly using a multilocus sequence analysis that included the internal transcribed spacer (ITS) regions of the nuclear ribosomal DNA and fragments of the translation elongation factor 1 alpha (Tef1), endochitinase CHI18-5 (Chi18-5), and actin 1 (Act1) genes. The most frequent species was Trichoderma longibrachiatum (26%), followed by Trichoderma citrinoviride (18%), the Hypocrea lixii/Trichoderma harzianum species complex (15%), the newly described species Trichoderma bissettii (12%), and Trichoderma orientale (11%). The most common anatomical sites of isolation in human clinical specimens were the respiratory tract (40%), followed by deep tissue (30%) and superficial tissues (26%), while all the animal-associated isolates were obtained from superficial tissue samples. Susceptibilities of the isolates to eight antifungal drugs in vitro showed mostly high MICs, except for voriconazole and the echinocandins.
MeSH terms
Actins; Animals; Antifungal Agents; Chitinases; Cluster Analysis; Communicable Diseases, Emerging; DNA, Fungal; DNA, Ribosomal Spacer; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Mycoses; Peptide Elongation Factor 1; Phylogeny; Trichoderma
More resources
Full text:
Europe PubMed Central; PubMed Central
EndNote: Download